Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Washington’s Covington & Burling has announced that Pfizer Inc.’s assistant general counsel has joined the firm. Judith Tytel joins the firm’s FDA, pharmaceutical, and government investigations groups as special counsel in New York. At Pfizer, Tytel worked on matters involving pharmaceutical marketing, medical and sales issues, Medicare/Medicaid issues, fraud and abuse issues, and compliance and government investigations. “Judi’s experience as in-house counsel at the world’s largest research-based biomedical and pharmaceutical company makes her an extremely valuable asset to our client base,” Ethan Posner, co-chairman of the firm’s pharmaceutical litigation and investigations group, said in a news release. Prior to joining Pfizer in 1983, Tytel was general counsel and assistant secretary of Long Island University. Covington & Burling has more than 650 lawyers in Brussels, London, New York, San Francisco and Washington.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.